Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
van Praag, H.M.
1980.
Central monoamine metabolism in depressions. II. Catecholamines and related compounds.
Comprehensive Psychiatry,
Vol. 21,
Issue. 1,
p.
44.
Burch, Earl A.
1983.
Primary care management of the depressed hypertensive patient.
Psychosomatics,
Vol. 24,
Issue. 4,
p.
389.
1983.
alpha-Methyldopa and depression: a clinical study and review of the literature.
American Journal of Psychiatry,
Vol. 140,
Issue. 5,
p.
534.
Mann, Anthony H.
1986.
The psychological aspects of essential hypertension.
Journal of Psychosomatic Research,
Vol. 30,
Issue. 5,
p.
527.
Polefrone, Joanna M.
Manuck, Stephen B.
Larkin, Kevin T.
and
Francis, M. Elizabeth
1987.
Medical Factors and Psychological Disorders.
p.
203.
Huber, G.
1988.
Psychiatrie der Gegenwart 6.
p.
197.
Wiklund, Ingela
Dimenäs, Elof
and
Wahl, Martine
1990.
Factors of importance when evaluating quality of life in clinical trials.
Controlled Clinical Trials,
Vol. 11,
Issue. 3,
p.
169.
Rauch, Scott L.
Stern, Theodore A.
and
Zusman, Randall M.
1991.
Neuropsychiatric Considerations in the Treatment of Hypertension.
The International Journal of Psychiatry in Medicine,
Vol. 21,
Issue. 3,
p.
291.
Coleman, Sean
and
Wilson, Ronnie
1991.
Psychiatric and Social Characteristics of Homeless Hostel Residents in Northern Ireland.
The Irish Journal of Psychology,
Vol. 12,
Issue. 3,
p.
316.
Patten, Scott B.
and
Love, Edgar J.
1994.
Neuropsychiatric Adverse Drug Reactions: Passive Reports to Health and Welfare Canada's Adverse Drug Reaction Database (1965-Present).
The International Journal of Psychiatry in Medicine,
Vol. 24,
Issue. 1,
p.
45.
Fraser, Henry S.
1996.
Reserpine: A tragic victim of myths, marketing, and fashionable prescribing.
Clinical Pharmacology & Therapeutics,
Vol. 60,
Issue. 4,
p.
368.
Siepmann, Martin
and
Kirch, Wilhelm
1998.
Reserpin-Diuretika-Kombinationen in der Therapie der arteriellen Hypertonie.
Medizinische Klinik,
Vol. 93,
Issue. 12,
p.
733.
Lavorato, Dina H.
and
Patten, Scott B.
1999.
Antihypertensive medications and depression, an historical perspective.
Pharmacoepidemiology and Drug Safety,
Vol. 8,
Issue. 5,
p.
355.
Yarnell, Eric
and
Abascal, Kathy
2001.
Treating Hypertension Botanically.
Alternative and Complementary Therapies,
Vol. 7,
Issue. 5,
p.
284.
Berger, S. Paul
Winhusen, Theresa M.
Somoza, Eugene C.
Harrer, Judy M.
Mezinskis, Juris P.
Leiderman, Deborah B.
Montgomery, Margaret A.
Goldsmith, R. Jeffrey
Bloch, Daniel A.
Singal, Bonita M.
and
Elkashef, Ahmed
2005.
A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence.
Addiction,
Vol. 100,
Issue. s1,
p.
58.
Winhusen, Theresa
Somoza, Eugene
Sarid-Segal, Ofra
Goldsmith, R. Jeffrey
Harrer, Judy M.
Coleman, Florence S.
Kahn, Roberta
Osman, Sabuhi
Mezinskis, Juris
Li, Shou-Hua
Lewis, Daniel
Afshar, Maryam
Ciraulo, Domenic A.
Horn, Paul
Montgomery, Margaret A.
and
Elkashef, Ahmed
2007.
A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.
Drug and Alcohol Dependence,
Vol. 91,
Issue. 2-3,
p.
205.
Huffman, Jeff C.
and
Stern, Theodore A.
2007.
Neuropsychiatric consequences of cardiovascular medications.
Dialogues in Clinical Neuroscience,
Vol. 9,
Issue. 1,
p.
29.
Lohoff, Falk W.
2010.
Membrane Transporters in Drug Discovery and Development.
Vol. 637,
Issue. ,
p.
165.
Erickson, Steven R.
Bostwick, Jolene R.
and
Guthrie, Sally K.
2011.
Psychiatry and Heart Disease.
p.
194.
Celano, Christopher M.
Freudenreich, Oliver
Fernandez-Robles, Carlos
Stern, Theodore A.
Caro, Mario A.
and
Huffman, Jeff C.
2011.
Depressogenic effects of medications: a review.
Dialogues in Clinical Neuroscience,
Vol. 13,
Issue. 1,
p.
109.